Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics
09:01am, Monday, 15'th Jan 2024
Quest Diagnostics' (DGX) new partnership is likely to leverage its oncology expertise and national scale.
Is Quest Diagnostics (DGX) Stock Undervalued Right Now?
11:19am, Wednesday, 10'th Jan 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Quest Diagnostics (DGX) to Boost Lab Services With New Buyout
02:17pm, Tuesday, 09'th Jan 2024
Quest Diagnostics' (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
03:02pm, Wednesday, 03'rd Jan 2024
Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.
Quest Diagnostics (DGX) Unveils the 88-Compound NPS Test Panel
08:16am, Wednesday, 20'th Dec 2023
Quest Diagnostics (DGX) launches the new 88-Compound NPS test panel to address the changing drug epidemic.
Quest Diagnostics' (DGX) Haystack Oncology Inks New Deal
09:01am, Monday, 18'th Dec 2023
Quest Diagnostics' (DGX) wholly owned subsidiary, Haystack Oncology, partners with the Rutgers Cancer Institute of New Jersey.
Quest Diagnostics (DGX) & CDC to Assess Hepatitis C Burden
09:01am, Friday, 08'th Dec 2023
Quest Diagnostics (DGX) and CDC expand research collaboration to better understand the Hepatitis C burden in the United States.
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
09:01am, Thursday, 30'th Nov 2023
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business.
Quest Diagnostics' (DGX) New Pact to Advance Cancer Screening
12:02pm, Wednesday, 22'nd Nov 2023
Quest Diagnostics' (DGX) latest partnership will increase the likelihood that Americans will eventually have an easy, reliable and accessible way to check for colorectal cancer.
Quest Diagnostics (DGX) Introduces Mobile Phlebotomy Service
12:02pm, Monday, 13'th Nov 2023
Quest Diagnostics (DGX) can offer patients and physicians a seamless connection to Quest Diagnostic's laboratory testing with the launch of Quest Mobile.
Quest Diagnostics (DGX) Tops Q3 Earnings, Gross Margin Dips
12:47pm, Tuesday, 24'th Oct 2023
Quest Diagnostics' (DGX) base business growth reflects the company's ongoing efforts to partner with health plans, hospitals and physicians amid a continued return to care.
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
09:46am, Tuesday, 24'th Oct 2023
Quest Diagnostics (DGX) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.36 per share a year ago.
Quest Diagnostics profit falls 12%, but beats estimate
07:03am, Tuesday, 24'th Oct 2023
Quest Diagnostics Inc. DGX, -1.84% said Tuesday its third-quarter profit dropped by 12.2% to $225 million, or $1.96 a share, from $256 million, or $2.17 a share, in the year-ago quarter. Adjusted thir
Quest Diagnostics (DGX) to Post Q3 Earnings: What's in Store?
09:47am, Thursday, 19'th Oct 2023
Quest Diagnostics (DGX) third-quarter 2023 results are likely to reflect continued strength in the base business.
Quest Diagnostics (DGX) Gains From New Alliances Amid FX Woes
12:47pm, Wednesday, 18'th Oct 2023
Quest Diagnostics' (DGX) recent acquisition of New York-Presbyterian's outreach assets adds to volume growth within Physician Lab Services.
